The ongoing epidemics of obesity is one main health concern of the present time. Overeating in some obese individuals shares similarities with the loss of control and compulsive behavior observed in drug-addicted subjects, suggesting that obesity may involve food addiction. Here, we review the contributions provided by the use of positron emission tomography to the current understanding of the cerebral control of obesity and food intake in humans. The available studies have shown that multiple areas in the brain are involved with the reward properties of food, such as prefrontal, orbitofrontal, somatosensory cortices, insula, thalamus, hypothalamus, amygdala, and others. This review summarizes the current evidence, supporting the concepts that i) regions involved in the somatosensory response to food sight, taste, and smell are activated by palatable foods and may be hyperresponsive in obese individuals, ii) areas controlling executive drive seem to overreact to the anticipation of pleasure during cue exposure, and iii) those involved in cognitive control and inhibitory behavior may be resistant to the perception of reward after food exposure in obese subjects. All of these features may stimulate, for different reasons, ingestion of highly palatable and energy-rich foods. Though these same regions are similarly involved in drug abusers and game-addicted individuals, any direct resemblance may be an oversimplification, especially as the heterogeneities between studies and the prevalent exclusion of sensitive groups still limit a coherent interpretation of the findings. Further work is required to comprehensively tackle the multifaceted phenotype of obesity and identify the role of food dependency in its pathophysiology.

Keywords:
PET, Drug addiction, Food addiction, Cerebral, 18F-fluorodeoxyglucose, Obesity, 18F-FDG
1.
Lutter M, Nestler EJ: Homeostatic and hedonic signals interact in the regulation of food intake. J Nutr 2009;139:629–632.
2.
Phelps ME: Positron emission tomography provides molecular imaging of biological processes. Proc Natl Acad Sci U S A 2000;97:9226–9233.
3.
Goldstone AP, Prechtl de Hernandez CG, Beaver JD, Muhammed K, Croese C, Bell G, Durighel G, Hughes E, Waldman AD, Frost G, Bell JD: Fasting biases brain reward systems towards high-calorie foods. Eur J Neurosci 2009;30:1625–1635.
4.
Volkow ND, Wang GJ, Telang F, Fowler JS, Thanos PK, Logan J, Alexoff D, Ding YS, Wong C, Ma Y, Pradhan K: Low dopamine striatal D2 receptors are associated with prefrontal metabolism in obese subjects: possible contributing factors. Neuroimage 2008;42:1537–1543.
5.
Hasselbalch SG, Knudsen GM, Videbaek C, Pinborg LH, Schmidt JF, Holm S, Paulson OB: No effect of insulin on glucose blood-brain barrier transport and cerebral metabolism in humans. Diabetes 1999;48:1915–1921.
6.
Hirvonen J, Virtanen KA, Nummenmaa L, Hannukainen JC, Honka MJ, Bucci M, Nesterov SV, Parkkola R, Rinne J, Iozzo P, Nuutila P: Effects of insulin on brain glucose metabolism in impaired glucose tolerance. Diabetes 2011;60:443–447.
7.
Lerche S, Brock B, Rungby J, Bøtker HE, Møller N, Rodell A, Bibby BM, Holst JJ, Schmitz O, Gjedde A: Glucagon-like peptide-1 inhibits blood-brain glucose transfer in humans. Diabetes 2008;57:325–331.
8.
Wang GJ, Volkow ND, Felder C, Fowler JS, Levy AV, Pappas NR, Wong CT, Zhu W, Netusil N: Enhanced resting activity of the oral somatosensory cortex in obese subjects. Neuroreport 2002;13:1151–1155.
9.
Morimoto A, Suzumi M, Sakata Y, Murakami N: Activation of brain regions in rats during food-intake operant behavior. Physiol Behav 1984;33:965–968.
10.
Pu YM, Wang JJ, Wang T, Yu QX: Cerebellar interpositus nucleus modulates neuronal activity of lateral hypothalamic area. Neuroreport 1995;6:985–988.
11.
Wang GJ, Volkow ND, Telang F, Jayne M, Ma J, Rao M, Zhu W, Wong CT, Pappas NR, Geliebter A, Fowler JS: Exposure to appetitive food stimuli markedly activates the human brain. Neuroimage 2004;21:1790–1797.
12.
Volkow ND, Wang GJ, Telang F, Fowler JS, Goldstein RZ, Alia-Klein N, Logan J, Wong C, Thanos PK, Ma Y, Pradhan K: Inverse association between BMI and prefrontal metabolic activity in healthy adults. Obesity (Silver Spring) 2009;17:60–65.
13.
Rolls ET: Taste and olfactory processing in the brain and its relation to the control of eating. Crit Rev Neurobiol 1997;11:263–287.
14.
Karhunen LJ, Vanninen EJ, Kuikka JT, Lappalainen RI, Tiihonen J, Uusitupa MI: Regional cerebral blood flow during exposure to food in obese binge eating women. Psychiatry Res 2000;99:29–42.
15.
Tataranni PA, Gautier JF, Chen K, Uecker A, Bandy D, Salbe AD, Pratley RE, Lawson M, Reiman EM, Ravussin E: Neuroanatomical correlates of hunger and satiation in humans using positron emission tomography. Proc Natl Acad Sci U S A 1999;96:4569–4574.
16.
Vandenbergh J, Dupont P, Fischler B, Bormans G, Persoons P, Janssens J, Tack J: Regional brain activation during proximal stomach distention in humans: A positron emission tomography study. Gastroenterology 2005;128:564–573.
17.
Stephan E, Pardo JV, Faris PL, Hartman BK, Kim SW, Ivanov EH, Daughters RS, Costello PA, Goodale RL: Functional neuroimaging of gastric distention. J Gastrointest Surg 2003;7:740–749.
18.
Ladabaum U, Minoshima S, Hasler WL, Cross D, Chey WD, Owyang C: Gastric distention correlates with activation of multiple cortical and subcortical regions. Gastroenterology 2001;120:369–376.
19.
Gautier JF, Chen K, Salbe AD, Bandy D, Pratley RE, Heiman M, Ravussin E, Reiman EM, Tataranni PA: Differential brain responses to satiation in obese and lean men. Diabetes 2000;49:838–846.
20.
Del Parigi A, Chen K, Gautier JF, Salbe AD, Pratley RE, Ravussin E, Reiman EM, Tataranni PA: Sex differences in the human brain’s response to hunger and satiation. Am J Clin Nutr 2002;75:1017–1022.
21.
Gautier JF, Del Parigi A, Chen K, Salbe AD, Bandy D, Pratley RE, Ravussin E, Reiman EM, Tataranni PA: Effect of satiation on brain activity in obese and lean women. Obes Res 2001;9:676–684.
22.
Le DS, Pannacciulli N, Chen K, Del Parigi A, Salbe AD, Reiman EM, Krakoff J: Less activation of the left dorsolateral prefrontal cortex in response to a meal: a feature of obesity. Am J Clin Nutr 2006;84:725–731.
23.
Del Parigi A, Chen K, Salbe AD, Hill JO, Wing RR, Reiman EM, Tataranni PA: Successful dieters have increased neural activity in cortical areas involved in the control of behavior. Int J Obes (Lond) 2007;31:440–448.
24.
Schmidt K, Nolte-Zenker B, Patzer J, Bauer M, Schmidt LG, Heinz A: Psychopathological correlates of reduced dopamine receptor sensitivity in depression, schizophrenia, and opiate and alcohol dependence. Pharmacopsychiatry 2001;34:66–72.
25.
Volkow ND, Wang GJ, Maynard L, Jayne M, Fowler JS, Zhu W, Logan J, Gatley SJ, Ding YS, Wong C, Pappas N: Brain dopamine is associated with eating behaviors in humans. Int J Eat Disord 2003;33:136–142.
26.
Volkow ND, Wang GJ, Fowler JS, Logan J, Jayne M, Franceschi D, Wong C, Gatley SJ, Gifford AN, Ding YS, Pappas N: ‘Nonhedonic’ food motivation in humans involves dopamine in the dorsal striatum and methylphenidate amplifies this effect. Synapse 2002;44:175–180.
27.
Inoue K, Kiriike N, Fujisaki Y, Okuno M, Ito H, Yamagami S: D2 receptors in the ventrolateral striatum are involved in feeding behavior in rats. Pharmacol Biochem Behav 1995;50:153–161.
28.
de Leeuw van Weenen JE, Auvinen HE, Parlevliet ET, Coomans CP, Schröder-van der Elst JP, Meijer OC, Pijl H: Blocking dopamine D2 receptors by haloperidol curtails the beneficial impact of calorie restriction on the metabolic phenotype of high-fat diet induced obese mice. J Neuroendocrinol 2011;23:158–167.
29.
Wang GJ, Volkow ND, Logan J, Pappas NR, Wong CT, Zhu W, Netusil N, Fowler JS: Brain dopamine and obesity. Lancet 2001;357:354–357.
30.
Murase S, Grenhoff J, Chouvet G, Gonon FG, Svensson TH: Prefrontal cortex regulates burst firing and transmitter release in rat mesolimbic dopamine neurons studied in vivo. Neurosci Lett 1993;157:53–56.
31.
Volkow ND, Chang L, Wang GJ, Fowler JS, Ding YS, Sedler M, Logan J, Franceschi D, Gatley J, Hitzemann R, Gifford A, Wong C, Pappas N: Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry 2001;158:2015–2021.
32.
Volkow ND, Wang GJ, Telang F, Fowler JS, Logan J, Jayne M, Ma Y, Pradhan K, Wong C: Profound decreases in dopamine release in striatum in detoxified alcoholics: possible orbitofrontal involvement. J Neurosci 2007;27:12700–12706.
33.
Volkow ND, Fowler JS, Wang GJ, Hitzemann R, Logan J, Schlyer DJ, Dewey SL, Wolf AP: Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse 1993;14:169–177.
34.
Volkow ND, Wang GJ, Begleiter H, Porjesz B, Fowler JS, Telang F, Wong C, Ma Y, Logan J, Goldstein R, Alexoff D, Thanos PK: High levels of dopamine D2 receptors in unaffected members of alcoholic families: possible protective factors. Arch Gen Psychiatry 2006;63:999–1008.
35.
Bonson KR, Grant SJ, Contoreggi CS, Links JM, Metcalfe J, Weyl HL, Kurian V, Ernst M, London ED: Neural systems and cue-induced cocaine craving. Neuropsychopharmacology 2002;26:376–386.
36.
Grant S, London ED, Newlin DB, Villemagne VL, Liu X, Contoreggi C, Phillips RL, Kimes AS, Margolin A: Activation of memory circuits during cue-elicited cocaine craving. Proc Natl Acad Sci U S A 1996;93:12040–12045.
37.
Wang GJ, Volkow ND, Fowler JS, Cervany P, Hitzemann RJ, Pappas NR, Wong CT, Felder C: Regional brain metabolic activation during craving elicited by recall of previous drug experiences. Life Sci 1999;64:775–784.
38.
Park HS, Kim SH, Bang SA, Yoon EJ, Cho SS, Kim SE: Altered regional cerebral glucose metabolism in internet game overusers: a 18F-fluorodeoxyglucose positron emission tomography study. CNS Spectr 2010;15:159–166.
39.
Henry PK, Murnane KS, Votaw JR, Howell LL: Acute brain metabolic effects of cocaine in rhesus monkeys with a history of cocaine use. Brain Imaging Behav 2010;4:212–219.
© 2012 S. Karger GmbH, Freiburg
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.